Torres Denice — SEC Form 4 filings
SEC reporting owner CIK 1820278. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-18 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GLAUKOS Corp (GKOS) | Director | 5 | — | — | 9 |
| 2seventy bio, Inc. (TSVT) | Director | 2 | — | — | 5 |
| Karuna Therapeutics, Inc. (KRTX) | Director | 1 | — | — | 5 |
| Seaport Therapeutics, Inc. (SPTX) | Director | 1 | — | — | 3 |
| Celldex Therapeutics, Inc. (CLDX) | Director | 2 | — | — | 2 |
Form 4 filings — Torres Denice
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-29 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4/A | GLAUKOS Corp (GKOS) | Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,878 @ $0 · Grant/award (A): 2,987 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Seaport Therapeutics, Inc. (SPTX) | Conversion (C): 13,406 · Grant/award (A): 12,258 (derivative) @ $0 · Conversion (C): 42,105 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 623 @ $0 | EDGAR |
| 2025-06-09 | 4 | Celldex Therapeutics, Inc. (CLDX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 461 @ $0 · Grant/award (A): 2,108 @ $0 · Grant/award (A): 3,149 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | 2seventy bio, Inc. (TSVT) | Disposition to issuer (D): 12,050 · Code (U): 19,510 · Disposition to issuer (D): 24,100 (derivative) | EDGAR |
| 2024-06-12 | 4 | 2seventy bio, Inc. (TSVT) | Grant/award (A): 12,050 @ $0 · Grant/award (A): 24,100 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | GLAUKOS Corp (GKOS) | Grant/award (A): 1,716 @ $0 · Grant/award (A): 1,246 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | Karuna Therapeutics, Inc. (KRTX) | Disposition to issuer (D): 990 @ $330 · Disposition to issuer (D): 25,000 (derivative) @ $225.74 · Disposition to issuer (D): 8,500 (derivative) @ $201.99 · Disposition to issuer (D): 5,000 (derivative) @ $227.04 · Disposition to issuer (D): 1,904 (derivative) @ $92.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1820278 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →